Allostery Investments LP Rezolute, Inc. Call Options Transaction History
Allostery Investments LP
- $7.85 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RZLT
# of Institutions
95Shares Held
59.4MCall Options Held
713KPut Options Held
19K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$129 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$36.9 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.56MShares$32.7 Million0.08% of portfolio
-
Ubs Group Ag3.04MShares$27.9 Million0.0% of portfolio
-
Great Point Partners LLC Greenwich, CT3.03MShares$27.8 Million11.22% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $356M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...